Inside Precision Medicine February 19, 2025
Jonathan D. Grinstein, PhD

Jonathan D. Grinstein, PhD, the North American Editor of Inside Precision Medicine, hosts a new series called Behind the Breakthroughs that features the people shaping the future of medicine. With each episode, Jonathan gives listeners access to their motivational tales and visions for this emerging, game-changing field.

Progress in cancer diagnostics has been slow. While there has been progress in cancer screening, including new tests like Cologuard for colorectal cancer, improved mammography, and HPV testing for cervical cancer, the only new cancer added to screening since the start of my career is lung cancer. Despite these advancements, only one in six cancers in the United States is detected through screening, underscoring the need for significant improvement. This is why the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Trends
“Precision Med Has Evolved as Badly As I Expected” And Other Takeaways From Former FDA Commissioner At PMWC
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025
India targets to sequence 10 million genomes
23andMe considers sale as cash runs low

Share This Article